Keep an eye on this and on all antibody-drug conjugated (ADC), it looks like a big portion of small and big pharma is moving toward that direction
Another antibody-drug conjugate got f... - Advanced Prostate...
Another antibody-drug conjugate got fast tracked for mCRPC: BNT324/DB-1311
Written by
Maxone73
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Another Lu-177 solution gets fast tracked: Lu-177-DGUL, secures 'GIFT' designation
"On Monday, the Ministry of Food and Drug Safety (MFDS) designated Lu-177-DGUL as the 11th agent to...
Oh guys, this one is good for mCRPC: Biologic Drug-Device Combination Immunotherapy Shows Promise for Patients with mCRPC
Just presented at 2024 AACR and used clinically on 15 patients
"Of the 13 evaluable patients, 11...
Update on ARV-110 for anyone looking for a trial with a new drug approach - first in class - fast tracked May 2019
"Arvinas is currently evaluating ARV-110 in a Phase 1 study for men with castration-resistant...
Recent study on Flubendazole for castration resistant PCa - Another repurposed drug
After reading donits recent post about ferroptosis I did a search on google Scholar and came up...
Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
FORT LAUDERDALE, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage...